Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report
Background Due to its unique pharmacologic properties, efficacy as an analgesic, and role as a first-line medication for the treatment of opioid use disorder, sublingual buprenorphine has emerged as a treatment for patients with concurrent chronic pain and opioid use disorders. One challenge to util...
Guardat en:
Autors principals: | , , , , , |
---|---|
Format: | Llibre |
Publicat: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Còpia 1 | Disponible |